黄芪干预糖尿病视网膜病变的有效成分及其作用机制研究进展

刘芮诚; 孔玲; 孙野; 王喜军

doi:10.6039/j.issn.1001-0408.2023.11.23

您当前的位置：

首页 >

文章列表页 >

黄芪干预糖尿病视网膜病变的有效成分及其作用机制研究进展

综述 | 更新时间：2023-06-09

- 黄芪干预糖尿病视网膜病变的有效成分及其作用机制研究进展
- Research progress about effective components of Astragali Radix in the intervention of diabetic retinopathy and its mechanism
- 中国药房 2023年34卷第11期页码：1404-1408
- 作者机构：
  
  1.黑龙江中医药大学国家中医药管理局中医方证代谢组学研究中心/国家中医药管理局中药血清药物化学重点研究室/中药材GAP研究中心，哈尔滨　150040
  2.广州中医药大学第二附属医院省部共建中医湿证国家重点实验室，广州　511400
- 作者简介：
  
  硕士研究生。研究方向：中医方证代谢组学。 E-mail：ruichengl2020@163.com
  教授，博士生导师，博士。研究方向：中药血清药物化学及中医方证代谢组学。E-mail：xijunw@sina.com
- 基金信息：
  
  黑龙江中医药大学科研基金项目(201808)
- DOI：10.6039/j.issn.1001-0408.2023.11.23
  中图分类号： R284;R285
- 纸质出版日期：2023-06-15，
  
  收稿日期：2022-10-16，
  
  修回日期：2023-05-15，
扫描看全文
刘芮诚,孔玲,孙野等.黄芪干预糖尿病视网膜病变的有效成分及其作用机制研究进展 ^Δ[J].中国药房,2023,34(11):1404-1408.

LIU Ruicheng,KONG Ling,SUN Ye,et al.Research progress about effective components of Astragali Radix in the intervention of diabetic retinopathy and its mechanism[J].ZHONGGUO YAOFANG,2023,34(11):1404-1408.
刘芮诚,孔玲,孙野等.黄芪干预糖尿病视网膜病变的有效成分及其作用机制研究进展 ^Δ[J].中国药房,2023,34(11):1404-1408. DOI： 10.6039/j.issn.1001-0408.2023.11.23.

LIU Ruicheng,KONG Ling,SUN Ye,et al.Research progress about effective components of Astragali Radix in the intervention of diabetic retinopathy and its mechanism[J].ZHONGGUO YAOFANG,2023,34(11):1404-1408. DOI： 10.6039/j.issn.1001-0408.2023.11.23.

摘要

糖尿病视网膜病变是糖尿病的一种常见并发症，对人类视力健康产生了很大威胁。近几年研究表明，黄芪中皂苷类、多糖类、黄酮类成分通过作用于核因子κB、缺氧诱导因子1α、神经胶质纤维酸性蛋白、谷氨酰胺合成酶、醛糖还原酶和多种微小核糖核酸等相关靶点，调节磷脂酰肌醇3-激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白、沉默信息调节因子1/核因子E2相关因子2、B细胞淋巴瘤2等信号通路，从而发挥抗炎、抗微血管病变、抗神经退行性病变、抗细胞凋亡的作用，进而达到治疗糖尿病视网膜病变的目的。

Abstract

Diabetic retinopathy （DR） is a common complication of diabetes， which causes a great threat to the health of human vision. Recent studies have shown that saponins， polysaccharides and flavonoids in Astragali Radix regulate phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin pathway， silent information regulator 1/nuclear factor erythroid 2-related factor 2 pathway， B-cell lymphoma-2 and other signaling pathways by acting on nuclear factor-κB， hypoxia-inducible factor-1α， glial fibrillary acidic protein， glutamine synthetase， aldose reductase， multiple miRNA and other related targets， so as to exert anti-inflammatory， anti-microangiopathy， anti-neurodegenerative disease and anti-apoptosis， and then achieve the purpose of treating DR.

关键词

糖尿病视网膜病变黄芪有效成分作用机制

Keywords

Astragali Radixactive componentmechanisms

references

ABU EL-ASRAR A M，AL-MEZAINE H S. Advances in the treatment of diabetic retinopathy[J]. Saudi J Ophthalmol，2011，25（2）：113-122.

PANG B，LI Q W，QIN Y L，et al. Traditional Chinese medicine for diabetic retinopathy：a systematic review and meta-analysis[J]. Medicine （Baltimore），2020，99（7）：e19102.

国家药典委员会. 中华人民共和国药典：一部[S]. 2020年版. 北京：中国医药科技出版社，2020：318.

NY V，HOUŠKA M L，PAVELA R，et al. Potential bene- fits of incorporating Astragalus membranaceus into the diet of people undergoing disease treatment：an overview[J]. J Funct Foods，2021，77：104339.

HU C，JIA W P. Therapeutic medications against diabetes：what we have and what we expect[J]. Adv Drug Deliv Rev，2019，139：3-15.

LEE D，LEE D H，CHOI S，et al. Identification and isolation of active compounds from Astragalus membranaceus that improve insulin secretion by regulating pancreatic β-cell metabolism[J]. Biomolecules，2019，9（10）：618.

LIU X，WANG B，SUN Y，et al. Astragalus root extract inhibits retinal cell apoptosis and repairs damaged retinal neovascularization in retinopathy of prematurity[J]. Cell Cycle，2019，18（22）：3147-3159.

JIN Q，HAO X F，XIE L K，et al. A network pharmaco- logy to explore the mechanism of Astragalus membranaceus in the treatment of diabetic retinopathy[J]. Evid Based Complement Alternat Med，2020，2020：8878569.

SU H F，SHAKER S，KUANG Y，et al. Phytochemistry and cardiovascular protective effects of Huang-Qi （Astragali Radix）[J]. Med Res Rev，2021，41（4）：1999-2038.

CHANG X，CHEN X，GUO Y，et al. Advances in chemical composition，extraction techniques，analytical me- thods，and biological activity of Astragali Radix[J]. Mo- lecules，2022，27（3）：1058.

WANG C J，HE F，HUANG Y F，et al. Discovery of chemical markers for identifying species，growth mode and production area of Astragali Radix by using ultra-high-performance liquid chromatography coupled to triple quadrupole mass spectrometry[J]. Phytomedicine，2020，67：153155.

ZHANG J Q，WU C X，GAO L，et al. Astragaloside Ⅳ derived from Astragalus membranaceus：a research review on the pharmacological effects[J]. Adv Pharmacol，2020，87：89-112.

TANG Z，HUANG G. Extraction，structure，and activity of polysaccharide from Astragali Radix[J]. Biomed Pharmacother，2022，150：113015.

LIU P，PENG Q H，TONG P，et al. Astragalus polysaccharides suppresses high glucose-induced metabolic memory in retinal pigment epithelial cells through inhibiting mitochondrial dysfunction-induced apoptosis by regulating miR-195[J]. Mol Med，2019，25（1）：21.

SHENG Z，JIANG Y，LIU J，et al. UHPLC-MS/MS analysis on flavonoids composition in Astragalus membranaceus and their antioxidant activity[J]. Antioxidants （Basel），2021，10（11）：1852.

ZHANG Y，CHEN C，ZHANG J. Effects and significance of formononetin on expression levels of HIF-1α and VEGF in mouse cervical cancer tissue[J]. Oncol Lett，2019，18（3）：2248-2253.

RÜBSAM A，PARIKH S，FORT P E. Role of inflammation in diabetic retinopathy[J]. Int J Mol Sci，2018，19（4）：942.

FORRESTER J V，KUFFOVA L，DELIBEGOVIC M. The role of inflammation in diabetic retinopathy[J]. Front Immunol，2020，11：583687.

FERNANDEZ-ROBREDO P，GONZÁLEZ-ZAMORA J，RECALDE S，et al. Vitamin D protects against oxidative stress and inflammation in human retinal cells[J]. Antioxidants （Basel），2020，9（9）：E838.

HERNÁNDEZ C，ARROBA A I，BOGDANOV P，et al. Effect of topical administration of somatostatin on retinal inflammation and neurodegeneration in an experimental model of diabetes[J]. J Clin Med，2020，9（8）：2579.

WANG Y，REN T J，ZHENG L C，et al. Astragalus saponins inhibits lipopolysaccharide-induced inflammation in mouse macrophages[J]. Am J Chin Med，2016，44（3）：579-593.

闫丰华，焦禄安，郑加军，等. 黄芪多糖对糖尿病模型大鼠视网膜病变及血清胱抑素C的影响[J]. 热带医学杂志，2019，19（7）：813-816，804.

UEMURA A，FRUTTIGER M，D’AMORE P A，et al. VEGFR1 signaling in retinal angiogenesis and microinflammation[J]. Prog Retin Eye Res，2021，84：100954.

ARRIGO A，ARAGONA E，BANDELLO F. VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy[J]. Ann Med，2022，54（1）：1089-1111.

LAZZARA F，TROTTA M C，PLATANIA C B M，et al. Stabilization of HIF-1α in human retinal endothelial cells modulates expression of miRNAs and proangiogenic growth factors[J]. Front Pharmacol，2020，11：1063.

刘俊辉，李春江，李玉涛. 黄芪多糖对糖尿病大鼠视网膜病变的保护作用[J]. 河北医科大学学报，2017，38（7）：797-800.

MARCHESI N，FAHMIDEH F，BOSCHI F，et al. Ocular neurodegenerative diseases：interconnection between retina and cortical areas[J]. Cells，2021，10（9）：2394.

ROSSINO M G，DAL MONTE M，CASINI G. Relationships between neurodegeneration and vascular damage in diabetic retinopathy[J]. Front Neurosci，2019，13：1172.

LIU Y，LI L L，PAN N X，et al. TNF-α released from retinal Müller cells aggravates retinal pigment epithelium cell apoptosis by upregulating mitophagy during diabetic retinopathy[J]. Biochem Biophys Res Commun，2021，561：143-150.

QIU A W，HUANG D R，LI B，et al. IL-17A injury to retinal ganglion cells is mediated by retinal Müller cells in diabetic retinopathy[J]. Cell Death Dis，2021，12（11）：1057.

SUBIRADA P V，PAZ M C，RIDANO M E，et al. A journey into the retina：Müller glia commanding survival and death[J]. Eur J Neurosci，2018，47（12）：1429-1443.

焦伟炜，刘学政. 黄芪甲苷对糖尿病大鼠视网膜Müller细胞的影响[J]. 解剖科学进展，2015，21（5）：512-514.

THAKUR S，GUPTA S K，ALI V，et al. Aldose reductase：a cause and a potential target for the treatment of diabetic complications[J]. Arch Pharm Res，2021，44（7）：655-667.

DING Y Z，YUAN S T，LIU X Y，et al. Protective effects of astragaloside Ⅳ on db/db mice with diabetic retinopathy[J]. PLoS One，2014，9（11）：e112207.

YANG S，ZHANG J，CHEN L. The cells involved in the pathological process of diabetic retinopathy[J]. Biomed Pharmacother，2020，132：110818.

PAVAN B，DALPIAZ A. Retinal pigment epithelial cells as a therapeutic tool and target against retinopathies[J]. Drug Discov Today，2018，23（9）：1672-1679.

余静，赵海岚，程凯尧，等. 黄芪皂苷通过调控蛋白激酶R样内质网激酶途径抑制高糖诱导的人视网膜色素上皮细胞自噬的研究[J]. 中国临床药理学与治疗学，2019，24（4）：361-368.

VASISHTA S，UMAKANTH S，ADIGA P，et al. Extrinsic and intrinsic factors influencing metabolic memory in type 2 diabetes[J]. Vascul Pharmacol，2022，142：106933.

TANG X，LI X，ZHANG D，et al. Astragaloside-Ⅳ alle- viates high glucose-induced ferroptosis in retinal pigment epithelial cells by disrupting the expression of miR-138-5p/Sirt1/Nrf2[J]. Bioengineered，2022，13（4）：8240-8254.

WANG T，ZHANG Z W，SONG C P，et al. Astragaloside-Ⅳ protects retinal pigment epithelial cells from apoptosis by upregulating miR‑128 expression in diabetic rats[J]. Int J Mol Med，2020，46（1）：340-350.

PENG Q H，TONG P，GU L M，et al. Astragalus polysaccharide attenuates metabolic memory-triggered ER stress and apoptosis via regulation of miR-204/SIRT1 axis in retinal pigment epithelial cells[J]. Biosci Rep，2020，40（1）：BSR20192121.

GAO L M，FU S，LIU F，et al. Astragalus polysaccharide regulates miR-182/bcl-2 axis to relieve metabolic memory through suppressing mitochondrial damage-mediated apoptosis in retinal pigment epithelial cells[J]. Pharmaco- logy，2021，106（9/10）：520-533.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

中药调控相关信号通路促进腱骨愈合的研究进展

中药通过调节Th17/Treg平衡干预胃癌的研究进展

黄酮类成分抗肺纤维化的作用机制研究进展

冲和膏促进肿疡消散的体内外机制研究

大豆苷元通过雌激素样作用防治骨质疏松症的机制研究现状